Feedback / Questions
CB-5339 - Cleave Therap
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-and-cleave-therapeutics-announce-clinical-trial-application-approval-for-cb-5339-in-patients-with-multiple-myeloma-in-china-301715199.html
Jan 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next